Literature DB >> 18786137

Long-term clinical outcomes of nocturnal hemodialysis patients compared with conventional hemodialysis patients post-renal transplantation.

Robert P Pauly1, Reem A Asad, James A Hanley, Andreas Pierratos, Jeffrey Zaltzman, Anne Chery, Christopher T Chan.   

Abstract

Nocturnal home hemodialysis (NHD) is a novel dialysis strategy associated with multiple advantages over conventional hemodialysis (CHD). Short- and long-term clinical outcomes of NHD patients after kidney transplantation are unknown. We hypothesized that the incidence of delayed graft function (DGF), patient and graft survival, and post-transplant estimated glomerular filtration rate (eGFR) is better among CHD-transplanted individuals than among those having received NHD. Of 231 NHD patients, 36 underwent renal transplantation between 1994 and 2006 and were matched to 68 transplanted CHD patients with a maximum follow-up of 11.7 yr. The incidence of DGF was not different between the two groups [NHD: 15/35 (42.9%) vs. CHD: 25/68 (36.8%) p = 0.43]. In modeling eGFR pre-transplant weight, donor age and recipient race were most predictive. Dialysis modality prior to transplantation influenced neither the level of eGFR post-transplantation (p = 0.34), nor the rate of eGFR decline. Patient survival was comparable between NHD and CHD groups (log-rank p = 0.91). Based on this analysis, it appeared that the incidence of DGF was similar between NHD- and CHD-transplanted patients and that pre-transplant modality did not impact on the level or rate of deterioration of post-transplant eGFR.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18786137     DOI: 10.1111/j.1399-0012.2008.00899.x

Source DB:  PubMed          Journal:  Clin Transplant        ISSN: 0902-0063            Impact factor:   2.863


  4 in total

1.  Contemporary dialysis: as good as transplantation?

Authors:  Heidi M Schaefer; J Harold Helderman
Journal:  Nat Rev Nephrol       Date:  2010-01       Impact factor: 28.314

Review 2.  How to overcome barriers and establish a successful home HD program.

Authors:  Bessie A Young; Christopher Chan; Christopher Blagg; Robert Lockridge; Thomas Golper; Fred Finkelstein; Rachel Shaffer; Rajnish Mehrotra
Journal:  Clin J Am Soc Nephrol       Date:  2012-10-04       Impact factor: 8.237

3.  Improved long-term survival with home hemodialysis compared with institutional hemodialysis and peritoneal dialysis: a matched cohort study.

Authors:  Helena Rydell; Kerstin Ivarsson; Martin Almquist; Mårten Segelmark; Naomi Clyne
Journal:  BMC Nephrol       Date:  2019-02-13       Impact factor: 2.388

4.  Safety and efficacy of the Tablo hemodialysis system for in-center and home hemodialysis.

Authors:  Troy J Plumb; Luis Alvarez; Dennis L Ross; Joseph J Lee; Jeffrey G Mulhern; Jeffrey L Bell; Graham Abra; Sarah S Prichard; Glenn M Chertow; Michael A Aragon
Journal:  Hemodial Int       Date:  2019-11-07       Impact factor: 1.812

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.